Published online: Sep 30, 2017 DOI: https://doi.org/10.18501/arrhythmia.2017.022 심방세동 환자에서의 뇌졸중 예방 차명진 서울대학교 의과대학 내과학교실 Stroke Prevention in Atrial Fibrillation Myung-Jin Cha...
Subclinical atrial fibrillation is short-lasting and asymptomatic and can usually be detected only by long-term continuous monitoring with pacemakers or defibrillators. Subclinical atrial fibrillat...
Despite the evidence-based guidelines for the management of atrial fibrillation (AF), serious gaps continue to exist between clinical knowledge and practice, leaving patients at risk for disabling...
This review updates previous reviews regarding the optimal risk stratification tools for stroke and bleeding prediction, and treatment options for stroke prevention in patients with atrial fibrilla...
The CHA2DS2-VASc Score for for Atrial Fibrillation Stroke Risk calculates stroke risk for patients with atrial fibrillation, possibly better than the CHADS2 score.
Despite relatively lower prevalence of atrial fibrillation (AF) in Asians (~1%) than in Caucasians (~2%), Asia has a much higher overall disease burden because of its proportionally larger aged pop...
Stroke prevention in atrial fibrillation patients with chronic kidney disease. by Robert G Hart, John W Eikelboom, K Scott Brimble, M Sean McMurtry, Alistair J Ingram. The Canadian journal of cardi...
Among patients with subclinical atrial fibrillation, apixaban resulted in a lower risk of stroke or systemic embolism than aspirin but a higher risk of major bleeding. (Funded by the Canadian Insti...
Atrial fibrillation (AF) is an irregular supraventricular tachyarrhythmia (any tachycardic rhythm originating above the ventricular tissue). It is characterized by uncoordinated atrial activation w...
Atrial fibrillation is found in a third of all ischaemic strokes, even more after post-stroke atrial fibrillation monitoring. Data from stroke registries show that both unknown and untreated or und...